glp-1 patch cause diarrhea 6 Common Side Effects of Taking Medication GLP-1 Medicines And Gut Bacterial

Diabetes Care 32:16001602 Greenfield JR, Farooqi IS, Keogh JM et al (2009) Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects

The safety and efficacy of liraglutide injection was evaluated in a 26-week clinical study that included patients with moderate renal impairment (eGFR 30 to 60 mL/min/1.73m 2) [see Clinical Studies (14.1)]

71% stop taking GLP-1s by 12 months 6 74% report gastrointestinal symptoms 7 65% report NO increased exercise after starting medication 8 This is why the Noom GLP-1 Rx Program with Noom GLP-1 Companion exists

These data support the findings of other researchers who showed GLP-1 drug use increased more than threefold from 2018 to 2022 in adult patients without type 2 diabetes

How might the Precision Peptide Genetic Test help me understand my response to tirzepatide

Theyre generally more potent than GLP-1 agonists due to their mechanism of action